Resources
22 Results (showing 1 - 10)
Results sorted by updated date (oldest first)
Results sorted by updated date (oldest first)
Posted 9/1/2020 (updated 9/2/2021)
This toolkit is intended to give prescribers a broad overview of medication utilization management techniques and describe ways that prescribers can facilitate patient access to needed medications. It focuses on prescribed medications that are filled by retail pharmacies; it does not cover the processes for methadone or specialty pharmacy products, such as injectable or implantable medications, all of which are commonly covered by a patient’s medical benefit rather than their pharmacy benefit.
Posted 9/30/2020 (updated 9/2/2021)
This page offers background information and tips for providers to keep in mind while using person-first language, as well as terms to avoid to reduce stigma and negative bias when discussing addiction.
Posted 10/19/2020 (updated 9/2/2021)
JBS can facilitate additional technical assistance and support related prescribing medication for opioid use disorder (MOUD). This support is recommended for clinicians who are contemplating or have recently begun prescribing MOUD and would like additional support.
Posted 10/21/2020 (updated 9/2/2021)
This study sought to identify best practices for retaining individuals in treatment and for achieving continuity of care between settings.
Posted 10/23/2020 (updated 9/2/2021)
The goal of this module is to train providers to initiate patients on buprenorphine safely and effectively.
Posted 10/23/2020 (updated 9/2/2021)
The objective of this report was to perform a systematic review of the beneficial and harmful effects of BUP-ER 100 mg and 300 mg for the management of moderate-to-severe OUD in adult patients who have been inducted and clinically stabilized on a transmucosal buprenorphine-containing product.
Posted 10/23/2020 (updated 9/2/2021)
This article offers data regarding offering buprenorphine treatment at a public hospital primary care setting using a home, unobserved induction protocol.
Posted 10/23/2020 (updated 9/2/2021)
The American Society of Addiction Medicine (ASAM) developed this National Practice Guideline for the Treatment of Opioid Use Disorder to provide information on evidence-based treatment of opioid use disorder.
Posted 10/23/2020 (updated 9/2/2021)
These pilot study results suggest comparable safety and effectiveness of unobserved and office induction and point toward utilization of non-inferiority design during future definitive protocol development.
Posted 11/18/2020 (updated 9/2/2021)
Healthcare provider burnout can lead to substance use disorder (SUD) and significant consequences for the individual, patients, and healthcare institutions. This webinar explored healthcare provider burnout, the scope of SUD in the medical community, and current pathways to recovery.